With cross-sectional patient studies in lab setting currently underway, a “Validate and Transfer II” enables longitudinal studies with home use.
Improved ankle mobility reduces complications of spastic paresis (e.g., contractures, high energy expenditure), allows renewed muscular control, and secondarily lowers the limitations in activities, enhancing quality of life.